fungal lung infectious disease
fungal lung infectious disease
Explore linked clinical trials. Standard reference: MONDO:000576636 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia | Bacterial Infections and Mycoses, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, Respiration Disorders, Respiratory Aspiration, fungal infectious disease, fungal lung infectious disease, interstitial lung disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT06892951 | |
| Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma | Bacterial Infections and Mycoses, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, pulmonary aspergilloma, pulmonary eosinophilia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not applicable | 2026-09-24 | NCT07828327 | |
| Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, blastomycosis, coccidioidomycosis, dermatomycosis, fungal infectious disease, fungal lung infectious disease, histoplasmosis, lung disorder, respiratory system disorder, respiratory tract infectious disorder, skin disorder, skin disorder caused by infection | Not yet recruiting | Phase 2 | 2026-09-04 | NCT07804368 | |
| Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis | Bacterial Infections and Mycoses, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, asthma, bronchial disorder, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, obstructive lung disease, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not applicable | 2026-08-11 | NCT07757841 | |
| ML-Based ABPA Recurrence Prediction and Clinical Utility | Bacterial Infections and Mycoses, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-07-20 | NCT07714863 | |
| Fungal Status and Prognosis in ABPA | Bacterial Infections and Mycoses, Hypersensitivity, Immediate, Infections, Invasive Fungal Infections, Invasive Pulmonary Aspergillosis, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, bronchial disorder, bronchiectasis, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-07-08 | NCT07690345 | |
| Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score | Bacterial Infections and Mycoses, Community-Acquired Infections, Community-Acquired Pneumonia, Disease Attributes, Emergencies, Infections, Invasive Fungal Infections, Invasive Pulmonary Aspergillosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumocystis infectious disease, aspergillosis, coinfection, fungal infectious disease, fungal lung infectious disease, infectious disease, lung disorder, pneumocystosis, pneumonia, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-07-02 | NCT07681583 | |
| Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 4 | 2026-06-01 | NCT07619027 | |
| Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction | Bacterial Infections and Mycoses, Disease Attributes, Hypersensitivity, Immediate, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-06-01 | NCT07611838 | |
| Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-04-23 | NCT06890078 | |
| Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis | Bacterial Infections and Mycoses, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, asthma, bronchial disorder, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, obstructive lung disease, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-04-21 | NCT07530770 | |
| A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA | Bacterial Infections and Mycoses, Hypersensitivity, Immediate, Infections, Invasive Fungal Infections, Invasive Pulmonary Aspergillosis, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-04-17 | NCT07362693 | |
| Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome | Bacterial Infections and Mycoses, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not applicable | 2026-04-07 | NCT05444946 | |
| Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS | AIDS, Bacterial Infections and Mycoses, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, Pneumocystis infectious disease, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, fungal infectious disease, fungal lung infectious disease, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Not applicable | 2026-03-27 | NCT03856229 | |
| Immune Status and Disease Control of Inflammatory Airway Diseases | Apnea, Bacterial Infections and Mycoses, Chronic Disease, Disease Attributes, Dyssomnias, Hypersensitivity, Immediate, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Hypersensitivity, Sleep Disorders, Intrinsic, allergic bronchopulmonary aspergillosis, aspergillosis, asthma, bronchial disorder, bronchiectasis, chronic obstructive pulmonary disease, disease, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, nervous system disorder, obstructive lung disease, obstructive sleep apnea syndrome, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not stated | 2026-03-25 | NCT07493629 | |
| Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors | Bacterial Infections and Mycoses, Digestive System Diseases, Fibrosis, Infections, Invasive Fungal Infections, Invasive Pulmonary Aspergillosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, aspergillosis, cirrhosis of liver, fungal infectious disease, fungal lung infectious disease, liver disorder, lung disorder, pneumonia, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-03-04 | NCT07238114 | |
| Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 3 | 2026-02-20 | NCT04851015 | |
| A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA | Bacterial Infections and Mycoses, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-01-23 | NCT07362667 | |
| Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 4 | 2026-01-21 | NCT07357103 | |
| How Long Should we Give Steroids for Patients With Severe PCP | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 4 | 2026-01-09 | NCT07328984 | |
| PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value | Bacterial Infections and Mycoses, Infections, Invasive Fungal Infections, Invasive Pulmonary Aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, lung disorder, pulmonary aspergilloma, respiratory system disorder | Recruiting | Not stated | 2026-01-02 | NCT07313527 | |
| Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology | Bacterial Infections and Mycoses, Infections, Mosquito-Borne Diseases, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, malaria, parasitic infectious disease, pneumocystosis, pneumonia, protozoa infectious disease, respiratory system disorder, respiratory tract infectious disorder, vector-borne disease | Recruiting | Not stated | 2025-12-08 | NCT07269314 | |
| Influenza Associated Aspergillosis In-depth Investigation | Bacterial Infections and Mycoses, Infections, Invasive Fungal Infections, Invasive Pulmonary Aspergillosis, RNA Virus Infections, aspergillosis, fungal infectious disease, fungal lung infectious disease, influenza, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Not stated | 2025-11-17 | NCT03748069 | |
| Corticosteroids for PJP in Non-HIV Immunocompromised Adults | Bacterial Infections and Mycoses, Community-Acquired Infections, Community-Acquired Pneumonia, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 3 | 2025-09-09 | NCT07152613 | |
| Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis | Bacterial Infections and Mycoses, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2025-07-04 | NCT07040332 |